Severe combined immunodeficiencies comprise a group of rare, monogenic diseases that are characterized by an early onset and a profound block in T lymphocyte development. In this Primer, Fischer and colleagues explain the pathogenesis of this disorder with a focus on current and future treatment strategies.
- Alain Fischer
- Luigi D. Notarangelo
- Jennifer M. Puck